• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素A对T细胞发育和克隆清除的影响。

Effects of cyclosporine A on T cell development and clonal deletion.

作者信息

Jenkins M K, Schwartz R H, Pardoll D M

机构信息

Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

出版信息

Science. 1988 Sep 23;241(4873):1655-8. doi: 10.1126/science.241.4873.1655.

DOI:10.1126/science.241.4873.1655
PMID:3262237
Abstract

Cyclosporine A (CsA) is an important immunosuppressive drug that is widely used in transplantation medicine. Many of its suppressive effects on T cells appear to be related to the inhibition of T cell receptor (TCR)-mediated activation events. Paradoxically, in certain situations CsA is responsible for the induction of a T cell-mediated autoimmunity. The effects of CsA on T cell development in the thymus were investigated to elucidate the physiologic events underlying this phenomenon. Two major effects were revealed: (i) CsA inhibits the development of mature single positive (CD4+8- or CD4-8+) TCR-alpha beta+ thymocytes without discernibly affecting CD4-8- TCR-gamma delta+ thymocytes and (ii) CsA interferes with the deletion of cells bearing self-reactive TCRs in the population of single positive thymocytes that do develop. This suggests a direct mechanism for CsA-induced autoimmunity and may have implications for the relative contribution of TCR-mediated signaling events in the development of the various T cell lineages.

摘要

环孢素A(CsA)是一种重要的免疫抑制药物,广泛应用于移植医学。它对T细胞的许多抑制作用似乎与抑制T细胞受体(TCR)介导的激活事件有关。矛盾的是,在某些情况下,CsA会导致T细胞介导的自身免疫。为了阐明这一现象背后的生理事件,研究了CsA对胸腺中T细胞发育的影响。结果揭示了两个主要影响:(i)CsA抑制成熟单阳性(CD4+8-或CD4-8+)TCR-αβ+胸腺细胞的发育,而对CD4-8-TCR-γδ+胸腺细胞没有明显影响;(ii)CsA干扰了在确实发育的单阳性胸腺细胞群体中携带自身反应性TCR的细胞的清除。这提示了CsA诱导自身免疫的直接机制,并且可能对TCR介导的信号事件在各种T细胞谱系发育中的相对贡献具有启示意义。

相似文献

1
Effects of cyclosporine A on T cell development and clonal deletion.环孢素A对T细胞发育和克隆清除的影响。
Science. 1988 Sep 23;241(4873):1655-8. doi: 10.1126/science.241.4873.1655.
2
Cyclosporin A inhibits positive selection and delays negative selection in alpha beta TCR transgenic mice.环孢素A抑制αβTCR转基因小鼠的阳性选择并延迟阴性选择。
J Immunol. 1994 Mar 15;152(6):2853-9.
3
Effects of cyclosporin A on T-cell development in organ-cultured foetal thymus.环孢素A对器官培养的胎胸腺中T细胞发育的影响。
Immunology. 1990 Oct;71(2):158-65.
4
Relationship of cyclosporine A-mediated inhibition of clonal deletion and development of syngeneic graft-versus-host disease.
J Immunol. 1991 Jul 15;147(2):391-7.
5
Effect of cyclosporin A on lymphopoiesis. II. Developmental defects of immature and mature thymocytes in fetal thymus organ cultures treated with cyclosporin A.环孢素A对淋巴细胞生成的影响。II. 环孢素A处理的胎儿胸腺器官培养物中未成熟和成熟胸腺细胞的发育缺陷。
J Immunol. 1989 Nov 15;143(10):3134-40.
6
Effect of cyclosporin A on the ontogeny of different T cell sublineages in chickens.环孢素A对鸡不同T细胞亚群个体发育的影响。
J Immunol. 1990 May 1;144(9):3257-65.
7
Phenotype, ontogeny, and repertoire of CD4-CD8- T cell receptor alpha beta + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage.CD4-CD8-T细胞受体αβ+胸腺细胞的表型、个体发生及谱系。自身抗原对T细胞受体Vβ使用的可变影响。
J Immunol. 1991 Feb 15;146(4):1134-41.
8
Development of TCR-gamma delta CD4-CD8+ alpha alpha but not TCR-alpha beta CD4-CD8+ alpha alpha i-IEL is resistant to cyclosporin A.TCR-γδ CD4-CD8+αα而非TCR-αβ CD4-CD8+αα i-IEL的发育对环孢素A具有抗性。
J Immunol. 1995 Nov 1;155(9):4224-30.
9
Effects of cyclosporine A on thymocyte differentiation in fetal thymus organ culture.环孢素A对胎胸腺器官培养中胸腺细胞分化的影响。
Cell Immunol. 1989 Oct 15;123(2):307-15. doi: 10.1016/0008-8749(89)90291-8.
10
Self-reactive T cells are present in the peripheral lymphoid tissues of cyclosporin A-treated mice.
Int Immunol. 1992 Dec;4(12):1341-9. doi: 10.1093/intimm/4.12.1341.

引用本文的文献

1
A real-world disproportionality analysis of cyclosporine from the FDA Adverse Event Reporting System (FAERS) database.基于 FDA 不良事件报告系统(FAERS)数据库的环孢素真实世界药物不良反应比例分析。
Braz J Med Biol Res. 2024 Jul 29;57:e13392. doi: 10.1590/1414-431X2024e13392. eCollection 2024.
2
Calcineurin inhibition rescues alloantigen-specific central memory T cell subsets that promote chronic GVHD.钙调磷酸酶抑制可挽救促进慢性移植物抗宿主病的同种抗原特异性中央记忆 T 细胞亚群。
J Clin Invest. 2024 Jun 3;134(11):e170125. doi: 10.1172/JCI170125.
3
A Novel Combination of Compound Heterozygous Variants in IFNGR1 Causing Complete IFNGR1 Deficiency.
IFNGR1基因中导致完全IFNGR1缺陷的复合杂合变异体的新型组合。
J Clin Immunol. 2024 Apr 27;44(5):111. doi: 10.1007/s10875-024-01716-7.
4
Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective.继发性噬血细胞性淋巴组织细胞增多症/巨噬细胞活化综合征的免疫病理学及潜在治疗策略:转化医学视角
Exp Mol Med. 2024 Mar;56(3):559-569. doi: 10.1038/s12276-024-01182-6. Epub 2024 Mar 6.
5
Mass cytometric analysis unveils a disease-specific immune cell network in the bone marrow in acquired aplastic anemia.质谱流式细胞分析揭示获得性再生障碍性贫血骨髓中疾病特异性免疫细胞网络。
Front Immunol. 2023 Nov 29;14:1274116. doi: 10.3389/fimmu.2023.1274116. eCollection 2023.
6
Cytomegalovirus breakthrough and resistance during letermovir prophylaxis.来特莫韦预防期间的巨细胞病毒突破和耐药性。
Bone Marrow Transplant. 2023 Apr;58(4):430-436. doi: 10.1038/s41409-023-01920-w. Epub 2023 Jan 24.
7
NFAT Factors Are Dispensable for the Development but Are Critical for the Maintenance of Foxp3 Regulatory T Cells.NFAT 因子对于 Foxp3 调节性 T 细胞的发育不是必需的,但对于其维持是至关重要的。
Cells. 2022 Apr 20;11(9):1397. doi: 10.3390/cells11091397.
8
Updates in chronic graft-versus-host disease.慢性移植物抗宿主病的研究进展。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):648-654. doi: 10.1182/hematology.2021000301.
9
Current Status and Future Directions in Graft--Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults.成人异基因血液和骨髓移植后移植物抗宿主病预防的现状与未来方向
Clin Hematol Int. 2020 Jan 28;2(1):5-12. doi: 10.2991/chi.d.200115.001. eCollection 2020 Mar.
10
Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?环孢素A:一种可用于治疗新冠肺炎的可重新利用的药物?
Front Med (Lausanne). 2021 Sep 6;8:663708. doi: 10.3389/fmed.2021.663708. eCollection 2021.